The results of treatment of 25 patients admitted from psychiatric institutions indicate that diazepam is the drug of first choice in the treatment of status epilepticus. The dangers of treatment appeared to result from combined use with other drugs. Respiratory depression occurred in one patient and hypotension in five patients, all of whom had been given intramuscular phenobarbitone in addition to intravenous diazepam. The two serious cases of hypotension had also been given parenteral paraldehyde.
Introduction
Previous reports which have established that parenterally administered diazepam (Valium) is effective in the treatment of status epilepticus also indicate that diazepam does not have severe depressant effects on the central nervous system, nor any serious side-effects. The absence of ill-effects is unusual for a potent drug, whereas the failure to recognize these has been common enough in the early experience of the use of many drugs.
Case Material
The case material consists of a consecutive series of 25 patients (13 male and 12 female) with status epilepticus transferred during a period of two years, in most cases as emergencies, from psychiatric hospitals to a neuropsychiatric unit. The group included all cases refractory to conventional methods of treatment.
The mean age of the patients was 39 (range 7 to 69) years 22 were aged 20 or more. The mean duration of the epilepsy was eight years (range 2 months to 32 years). During the episodes of status epilepticus 14 patients did not regain consciousness between seizures and nine only partially regained consciousness. The only two subjects without impairment of consciousness had focal motor seizures-.epilepsia partialis continua in one and Jacksonian epilepsy in the other.
The initial dose of diazepam was given intravenously over at least five minutes, with particular attention to blood pressure changes. In 17 cases the effects of diazepam were monitored with the electroencephalograph. In those cases requiring repeated injections the rate of administration was assessed from the response to 10 mg. When the seizures were arrested fairly readily the subsequent dose of diazepam was given intramuscularly; more refractory cases received intermittent intravenous injections, and in cases particularly difficult to control the drug was given continuously in an intravenous drip.
The patient's normal anticonvulsant medication was continued during treatment with diazepam. Phenobarbitone and phenytoin were given intramuscularly when there was a poor or limited response to diazepam, and in two cases the supplementary treatment included intramuscular paraldehyde.
Results
The initial dose of diazepam, which in individual cases ranged from 2.5 to 40 mg., brought prompt arrest of the seizures of D 11 patients. Another five had an almost equally good responsein one the continuous seizure activity ceased eight minutes after the slow administration of 50 mg. of diazepam, and in the other four cases occasional fits persisted for some hours after the initial dose had arrested the continuous seizure activity. An incomplete but useful control of seizure activity was obtained for two patients and seven had a poor response.
Four patients had more than one episode treated with diazepam, and in one case the second episode, which occurred in the terminal phase of the patient's illness, was not controlled as well as the first.
Complications
One patient died four days after her second episode of status epilepticus. She had been moribund for some weeks and the epilepsy appeared to be a terminal phenomenon. (Maspoli, 1967) . In the dog rapid injection produces a dose-dependent decrease in blood pressure (Brassier et al., 1966) . Chai and Wang (1966) The two patients who became hypotensive to a serious degree had some factors in common. Both received relatively large doses and both had inhalation pneumonia. They were given other drugs as well, receiving paraldehyde and phenobarbitone intramuscularly.
The factor in common for all the cases of hypotension in this series was that the patients had been given phenobarbitone intramuscularly in conjunction with diazepam. Only seven of the other 22 episodes in the series had been treated with this combination. The relationship is statistically significant (Fisher exact probability test, P<0.02, one-tailed).
Hypotension does not seem to have occurred in the course Of the extensive use of diazepam in the treatment of tetanus, even though barbiturates were also given in many cases (FemiPearse, 1966; Hendrickse and Sherman, 1966) . However, it has been reported in cases of status epilepticus treated with diazepam. Parsonage and Norris (1967) reported hypotension to have preceded death in one of their nine cases, but did not believe the fall in blood pressure was due to diazepam. Sawyer et al. (1968) observed hypotension in one case in which parenteral barbiturate had also been given. Prensky et al. (1967) noted hypotension in three cases in their tables, though they referred to only two cases in their text. One of these had been given parenteral barbiturates in addition to diazepam. As in our own scries, all the patients who became hypotensive were adults.
If allowance is made for the high proportion of children in the series reported to date, the incidence of hypotension as a complication of diazepam treatment of status epilepticus in the adult assumes greater significance. The seven reported cases of serious hypotension, including two in the present series, were observed in four series totalling 70 adult subjects. Five of the seven patients had been treated with other drugs as well, in four cases the drugs being parenteral barbiturates. Furthermore, it would appear that in other series of adults in which hypotension was not observed diazepam was usually used alone in treating the status epilepticus.
The dangers of overzealous and excessive treatment in the management of status epilepticus have been emphasized in recent years. Lombroso (1966) pointed out that the patient in status epilepticus is peculiarly susceptible to the depressant effects of drugs. He found that almost a quarter of a group of children who had succumbed in status epilepticus had cardiac or respiratory arrest, or both, shortly after the intravenous administration of a hypnotic agent. The unwise pursuit of an ideal in which the seizures are completely arrested may result in the administration of one drug after another, adding the risk of largely unknown synergistic effects. In fact, some cases that are partly refractory to treatment make satisfactory progress if allowed to continue with partial or modified seizures until the episode ceases in its own time (Sawyer et al., 1968 
INTRODUCTION
Animal experiments have usually failed to show any convincing lesions in the kidney after prolonged administration of analgesics (Shelley, 1967) . Papillary necrosis is the characteristic lesion in analgesic nephropathy in man (Kincaid-Smith, 1967a) , and this paper reports the occurrence of papillary necrosis in a high percentage of rats receiving a proprietary aspirin, phenacetin, and caffeine (A.P.C.) mixture. Papillary necrosis was not noted in rats receiving twice as much phenacetin as that contained in the A.P.C. mixture.
MATERIALS AND METHODS
Wistar rats weighing 150 g. received by gavage on five days each week phenacetin 500 mg./kg/day or a proprietary analgesic mixture containing phenacetin 210 mg./kg./day, aspirin 210 mg./kg./day, and caffeine 80 mg./kg./day. A control group did not receive drugs. Half the animals in each group were deprived of fluids overnight (see Table) . This produced a striking rise in urine osmolarity and may thus have potentiated any toxic effect of the analgesics on the medulla.
Findings in animals killed at three months and five months have been reported (Kincaid-Smith et al., 1968) . It had been planned to continue the experiment for a year, but very heavy losses in the A.P.C. group after six months made it necessary to kill all the remaining animals between six and nine months.
RESULTS
Ten out of 18 rats receiving the proprietary A.P.C. mixture for more than six months developed papillary necrosis (see Table) . A further 10 rats receiving A.P.C. died over this period but were not satisfactory for examination owing to cannibalism and autolysis. Papillary necrosis was noted in six (75%) out of eight rats deprived of fluids overnight and in 4 (40%) out of 10 rats with continuous access to water. Papillary necrosis was not noted in the control group (28) or in rats receiving phenacetin alone (27) in a dose of 500 mg./kg./day. Four animals with papillary necrosis showed cortical scars, and these could be seen in serial sections to result from atroohy of tubules which were obstructed in the papillary lesion. The cortex was normal in animals with normal papillae except for a patchy increase in lipofuchsin pigment in tubular cells in some animals receiving phenacetin and A.P.C.
Some abnormalities were noted in the papillae in rats receiving phenacetin alone ; these included patchy cast formation and an unidentified pigmented substance in the interstitium of the medulla in a few animals. The lesions in the vasa recta noted in the early months of this experiment (Kincaid-Smith et al., 1968) did not seem to advance between six and nine months and no definite thrombosis or occlusion of these vessels was noted. Platelets were, however, noted adhering to the endothelium in some abnormal vessels.
DISCUSSION
We have confirmed the high incidence of papillary necrosis in rats given a proprietary A.P.C. mixture for between six and nine months and also the pathogenesis of the renal lesions in these animals. Papillary necrosis precedes cortical scars, and these result from atrophy of tubules obstructed by the necrosis in the papilla (Abrahams and Levin, 1967 ; Kincaid-Smith et al., 1968) . This is a similar pathogenesis to that described in analgesic nephropathy in man (Kincaid-Smith, 1967a) .
The dose of A.P.C. mixture given to the rats was equivalent in mg./kg./day to that taken by some patients with analgesic nephropathy.
Phenacetin has been generally assumed to be the cause of renal damage in analgesic nephropathy in man, though evidence against phenacetin depends mainly on the fact that it is present in most of the mixtures said to cause renal damage. Recently attention has been drawn to the lack of direct evidence against
